Abstract
This is thought to be the first report of the use of interferon therapy by intraventricular administration in adult-onset subacute sclerosing panencephalitis. A 22-year-old female patient with subacute sclerosing panencephalitis was treated for three months with interferon by the intraventricular route and methisoprinol (inosiplex) by mouth. There was no obvious clinical improvement during this time, and the cerebrospinal-fluid measles antibody titre remained elevated. The lack of effect of therapy could be attributed partly to the patient's age and to the rapidly progressive deterioration in her condition before treatment. No significant side-effects were associated with this therapy. Further trials of these medications in adult-onset subacute sclerosing panencephalitis are indicated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
